There is some promising evidence that restoring IDO function can restore normoglycemia in T1D, and IDO-involved pathways, such as the TLR9-IDO axis, may be valuable targets in the prevention and treatment of the disease (17, 20). The gene discussed is TLR9; the disease is type 1 diabetes mellitus.